Login / Signup

Recombinant angiotensin II therapy in a child with cardiac dysfunction and Pandoraea and Candida sepsis.

Michael E KimStuart L GoldsteinMeghan M Chlebowski
Published in: Cardiology in the young (2023)
Recombinant angiotensin II is an emerging drug therapy for refractory hypotension. Its use is relevant to patients with disruption of the renin-angiotensin-aldosterone system denoted by elevated direct renin levels. We present a child that responded to recombinant angiotensin II in the setting of right ventricular hypertension and multi-organism septic shock.
Keyphrases